When a drug is substituted under this subchapter, including the substitution of an interchangeable biological product, the pharmacist shall record on the prescription form the drug substituted by name and manufacturer, and retain the form for inspection by District officials. The pharmacist shall also label the prescription container with the name of the drug substituted, unless the prescribing physician writes “do not label,” or words of similar import, on the prescription, or, in communicating the prescription by telephone, orders that the container not be so labelled.
(Sept. 10, 1976, D.C. Law 1-81, title III, § 304, 23 DCR 2460; Mar. 11, 2010, D.C. Law 18-118, § 2(e), 57 DCR 901; Oct. 20, 2020, D.C. Law 23-133, § 2(f), 67 DCR 9880.)
1981 Ed., § 33-734.
1973 Ed., § 33-834.
D.C. Law 18-118 substituted “this subchapter” for “§ 48-803.02”.
Structure District of Columbia Code
Chapter 8 - Prescription Drug Price Information
Subchapter III - Substitution of Therapeutically Equivalent Drugs
§ 48–803.01. Generically equivalent drug formulary; therapeutic interchange list
§ 48–803.02. Dispensing of generically equivalent drug product or interchangeable biological product
§ 48–803.03. Dispensing of substitute drug products — conditions
§ 48–803.03a. Dispensing of substitute drug products by pharmacists — notification of substitution
§ 48–803.04. Dispensation of equivalent products by pharmacists — Recording and labeling required